These medications are expensive due to high research costs, complex manufacturing processes, patent protection, and rising demand with limited supply
Thats why its a good choice for people who have this problem a lot
As the world's first once-weekly GLP-1 receptor agonist formulation for long-term weight management, global large-scale clinical studies - the STEP program and the SELECT study have demonstrated Wegovy 's efficacy in achieving sustained weight loss and improving obesity-related health outcomes
These can make daily life hard, as B12 is key for energy and brain health
However, like many GLP-1 receptor agonists , Tirzepatide can cause gastrointestinal side effects , with diarrhea being one of the most common
On average, people taking GLP-1 Treatments, Semaglutide or Tirzepatide eat about 30% less food than they would otherwise